This option features courses on the latest advances in hormone science research. This course bundle has been specifically curated for basic scientists and endocrine researchers, featuring top rated educational content from ENDO 2021.

To view the full ENDO program and speaker disclosures by session, please visit the program planner.

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
ENDO 2021 virtual meeting received general support from Amgen, Inc.; Concept Therapeutics; Radius Health Inc.; Strongbridge BioPharma; the Leona M. and Harry B. Helmsley Charitable Trust; Ultragenyx Pharmaceutical; Zealand Pharma.